1. Home
  2. ENTX vs BWEN Comparison

ENTX vs BWEN Comparison

Compare ENTX & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.18

Market Cap

62.6M

Sector

Health Care

ML Signal

HOLD

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$2.50

Market Cap

51.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
BWEN
Founded
2010
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
62.6M
51.0M
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
ENTX
BWEN
Price
$1.18
$2.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$9.00
$6.00
AVG Volume (30 Days)
135.1K
118.2K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
360.00
EPS
0.25
0.23
Revenue
$42,000.00
$146,785,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.37
P/E Ratio
$4.48
$10.48
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$1.49
52 Week High
$3.22
$4.15

Technical Indicators

Market Signals
Indicator
ENTX
BWEN
Relative Strength Index (RSI) 47.82 56.88
Support Level $0.96 $1.93
Resistance Level $1.38 $2.78
Average True Range (ATR) 0.10 0.17
MACD -0.00 0.03
Stochastic Oscillator 23.08 53.33

Price Performance

Historical Comparison
ENTX
BWEN

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: